Importance of pacemaker noise reversion as a potential mechanism of pacemaker-ICD interactions

PACE - Pacing and Clinical Electrophysiology

Volumn 21, Issue 5, 1998, Pages 1111-1121

  Glikson, Michael ^a,b   Trusty, Jane M ^a   Grice, Suellen K ^a   Hayes, David L ^a   Hammill, Stephen C ^a   Stanton, Marshall S ^a  

^a MAYO CLINIC   (United States)

^b SHEBA MEDICAL CENTER   (Israel)

Author keywords

Asynchronous pacing; Implantable cardioverter defibrillator; Noise reversion; Pacemaker

Indexed keywords

ADULT; AGED; ARTICLE; ARTIFICIAL HEART PACEMAKER; CARDIOVERSION; CLINICAL ARTICLE; DEFIBRILLATION; DEVICE; FEMALE; HEART PACING; HEART VENTRICLE FIBRILLATION; HUMAN; IMPLANTATION; MALE; NOISE REDUCTION; REFRACTORY PERIOD; TELEMETRY;

BRADYCARDIA; DEFIBRILLATORS, IMPLANTABLE; ELECTRICITY; ELECTROCARDIOGRAPHY; ELECTRODES, IMPLANTED; EQUIPMENT FAILURE; EVALUATION STUDIES; HUMANS; PACEMAKER, ARTIFICIAL; PROSPECTIVE STUDIES; TACHYCARDIA, VENTRICULAR;

EID: 0031958610     PISSN: 01478389     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1540-8159.1998.tb00158.x     Document Type: Article

References (10)

1. Calkins H, Brinker J, Veltri EP, et al. Clinical interactions between pacemakers and automatic implantable cardioverter-defibrillators. J Am Coll Cardiol 1990; 16:666-673.
2. Stroobandt R, Willems R, Sinnaeve A. Combined automatic implantable cardioverter-defibrillator and permanent pacemaker systems. In A Andries, P Brugada, R Stroobandt (eds.): How to Face "The Faces" of Cardiac Pacing. Dordrecht, The Netherlands, Kluwer Academic Publishers, 1992, pp. 221-227.
3. Epstein AE, Kay GN, Plumb V, et al. Combined automatic implantable cardioverter-defibrillator and pacemaker systems: Implantation techniques and follow-up. J Am Coll Cardiol 1989; 13:121-131.
4. Singer I, Guarnieri T, Kupersmith J. Implanted automatic defibrillators: Effects of drugs and pacemakers. PACE 1988; 11:2250-2262.
5. Luceri RM, Brownstein SM, Habal SM, et al. Device-device and drug-device interactions. In SS Barold, J Mugica (eds.): New Perspectives in Cardiac Pacing 2. Mount Kisco, NY, Futura Publishing Company, Inc., 1991, pp. 527-544.
6. Epstein AE, Wilkoff BL. Pacemaker-defibrillator interactions. In KA Ellenbogen, GN Kay, BL Wilkoff (eds.): Clinical Cardiac Pacing. Philadelphia, WB Saunders Co., 1995, pp. 757-769.
7. Clemo HF, Ellenbogen KA, Belz MK, et al. Safety of pacemaker implantation in patients with transvenous (nonthoracotomy) implantable cardioverter defibrillators. PACE 1994; 17(Pt. II):2285-2291.
8. Frohlig G, Dyckmans J, Doenecke P, et al. Noise reversion of a dual chamber pacemaker without noise. PACE 1986; 9:690-696.
9. Del Negro A, Cohen A, Miller F, et al. Automatic extension of the ventricular refractory period: A cause of sensing failure during tachycardia in dual chamber pacemakers. (abstract) PACE 1986; 9:304.
10. Strathmore NF. Interference in cardiac pacemakers. In KA Ellenbogen, GN Kay, BL Wilkoff (eds.): Clinical Cardiac Pacing. Philadelphia, WB Saunders Co., 1995, pp. 770-779.